OTCMKTS:CPMD Golden Dragon (CPMD) Stock Price, News & Analysis $0.0030 0.00 (0.00%) As of 03:34 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsSEC FilingsBuy This Stock About Golden Dragon Stock (OTCMKTS:CPMD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Golden Dragon alerts:Sign Up Key Stats Today's Range$0.0030▼$0.003050-Day Range N/A52-Week Range$0.0001▼$0.0110Volume36,666 shsAverage Volume194,490 shsMarket Capitalization$1.98 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview CannaPharmaRX, Inc. operates in the cannabis industry in Canada. It evaluates, negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada. Read More Receive CPMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Golden Dragon and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CPMD Stock News HeadlinesCannapharmaRX Updates on Alberta Facility Progress and International Export StrategyDecember 4, 2024 | finance.yahoo.comPSIQ Profile Solutions, Inc.August 16, 2024 | seekingalpha.comCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holding investments longer to using tax-advantaged accounts and strategic loss offsetting, there are ways to reduce your exposure. SmartAsset outlines three capital gains tax strategies for seniors and offers a free tool to connect you with vetted fiduciary financial advisors who can help tailor these tactics to your situation.August 28 at 2:00 AM | SmartAsset (Ad)CannaPharmaRX, Inc. (CPMD)May 22, 2024 | finance.yahoo.comCannaPharmaRx to Host Investor Conference CallMay 20, 2024 | finance.yahoo.comCORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference CallMay 20, 2024 | finance.yahoo.comCannapharmarx, Inc.: CannapharmaRx Receives First Purchase Order and Begins Shipment of ProductMarch 14, 2024 | finanznachrichten.deCannaPharmaRx, Inc.: CannaPharmaRx Completes First HarvestsMarch 12, 2024 | finanznachrichten.deSee More Headlines CPMD Stock Analysis - Frequently Asked Questions How have CPMD shares performed this year? Golden Dragon's stock was trading at $0.0081 at the start of the year. Since then, CPMD stock has decreased by 63.0% and is now trading at $0.0030. How were Golden Dragon's earnings last quarter? Golden Dragon Holding Co. (OTCMKTS:CPMD) released its earnings results on Thursday, April, 10th. The company reported ($0.01) earnings per share for the quarter. The business had revenue of $0.48 million for the quarter. How do I buy shares of Golden Dragon? Shares of CPMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Golden Dragon own? Based on aggregate information from My MarketBeat watchlists, some other companies that Golden Dragon investors own include FuelCell Energy (FCEL), Blackstone (BX), Global Helium (HECOF), Trillium Therapeutics (TRIL), AFC Gamma (AFCG) and American Lithium (AMLI). Company Calendar Last Earnings4/10/2025Today8/28/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - DRUGS Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:CPMD CIK1081938 Webwww.cannapharmarx.com Phone(949) 652-6838Fax720-875-1905Employees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$9.91 million Net Margins-423.36% Pretax Margin-415.58% Return on EquityN/A Return on Assets-34.17% Debt Debt-to-Equity RatioN/A Current Ratio0.04 Quick Ratio0.01 Sales & Book Value Annual Sales$820 thousand Price / Sales2.42 Cash FlowN/A Price / Cash FlowN/A Book Value($0.04) per share Price / Book-0.08Miscellaneous Outstanding Shares660,626,000Free Float652,236,000Market Cap$1.98 million OptionableNot Optionable Beta2.12 Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (OTCMKTS:CPMD) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Golden Dragon Holding Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Golden Dragon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access